Ask AI
ProCE Banner Activity

Optimizing Mantle Cell Lymphoma Care: Case-Based Guidance From EU Experts

Slideset

Downloadable slides covering the current treatment algorithm, guidelines, and evidence-based approaches for the optimal integration of available treatments into the management of patients with mantle cell lymphoma (MCL) with careful consideration of patients’ age, fitness level, presence of high-risk features, preexisting comorbidities, and concomitant medications.

Released: May 29, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for global hematology/oncology physician specialists and other healthcare professionals providing care for patients with mantle cell lymphoma. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Plan BTK inhibitor–based combination strategies for patients with treatment-naive MCL, considering new indications, expert recommendations, and available efficacy and safety evidence

  • Select chemotherapy-free treatment strategies for appropriate patients with MCL

  • Manage treatment-related adverse events associated with targeted therapies alone or in combination to extend duration on treatment and improve clinical outcomes